Agenda

September 25, 2026
Non-CME/CE Bonus Presentation
The History, the Present, the Future: Kevzara® (sarilumab) in RA, PMR and pJIA
11:00 am
 — 
11:45 am
Presentations In This Session

This program will highlight the critical role of IL-6 in the pathogenesis of a range of rheumatic diseases such as RA, PMR, and pJIA; review the efficacy data and safety profile over 10 years of studies; and explore the latest data on pJIA, the most recent indication.